Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on August 12, 2015, to consider the un-Audited Financial Results of the Company for the quarter ended June 30, 2015 (Q1). Further, the ‘Trading Window’ of the Company shall remain closed from August 03, 2015 to August 14, 2015, in view of consideration of the Un-Audited Financial Results of the Company for the quarter ended June 30, 2015 at the Board Meeting to be held on August 12, 2015. During this period any purchase, sale or other dealings in the shares of the Company is prohibited to all the Directors / Officers / Employees / Connected Persons of the Company.
The above information is a part of company’s filings submitted to BSE.
